Business News›Sun Pharma Global FZE
SEARCHED FOR:
SUN PHARMA GLOBAL FZE
Stock market update: Nifty Pharma index advances 0.4% in an upbeat market
The Nifty Pharma index was trading 0.4 per cent up at 19174.15.
Indian pharmaceutical industry set for major transformation: Dilip Shanghvi
At an annual meeting of the USA-India Chamber of Commerce in Boston, Shanghvi told a gathering of leading multinational drug makers about the "clear positive improvements" that are taking place in India. Sun Pharma itself has built a pipeline of over 10 specialty and innovative drugs in the US. It's done this through acquisitions of late-stage drugs in clinical trials and building commercial teams around them. For Indian companies that have grown by making copies of innovative drugs, gaining presence in innovative drugs is considered tough as this segment is dominated by giant corporations such as Pfizer, Novartis, Roche, Eli Lilly and Bristol Myers Squibb.
Mcap of BSE-listed companies soar to all-time high of Rs 406.52 lakh cr
The market capitalisation of BSE-listed companies soared to an all-time high of Rs 406.52 lakh crore on Monday thanks to a rally in equities where the BSE Sensex climbed over 1 per cent.
Stock market update: Nifty Pharma index advances 0.55% in an upbeat market
The Nifty Pharma index was trading 0.55 per cent up at 19099.6.
Stock market update: Nifty Pharma index advances 0.62%
The Nifty Pharma index closed 0.62 per cent up at 18994.65.
Stock market update: Nifty Pharma index advances 0.31% in a weak market
The Nifty Pharma index was trading 0.31 per cent up at 18937.2.
- Go To Page 1
Mcap of BSE-listed cos at record peak of Rs 404 lk cr
The market capitalisation of BSE-listed companies jumped to a lifetime peak of Rs 404.18 lakh crore on Thursday helped by a five-day rally in benchmark indices, making investors richer by Rs 11.29 lakh crore.Stock market update: Nifty Pharma index advances 1.57%
The Nifty Pharma index closed 1.57 per cent up at 18878.15.Stock market update: Nifty Pharma index advances 0.73% in an upbeat market
The Nifty Pharma index was trading 0.73 per cent up at 18721.25.Stock market update: Nifty Pharma index falls 0.96%
The Nifty Pharma index closed 0.96 per cent down at 18463.75.Sensex, Nifty end marginally higher; RIL limits upside
The 30-share BSE benchmark Sensex edged up 90 points or 0.12% to settle at 73,738 and the broader NSE Nifty rose 32 points or 0.14% to end at 22,368. Bharti Airtel, ITC, Infosys, SBI, Maruti, and Tata Motors were the top contributors to the Sensex.Stock market update: Nifty Pharma index falls 0.4% in an upbeat market
The Nifty Pharma index was trading 0.4 per cent down at 18568.15.Staff safety on India Inc radar in troubled West Asia
Indian companies are closely monitoring the safety of employees in Israel, a West Asian innovation hub, amid the intensifying Israel-Iran conflict. Sun Pharma, with a presence in Israel through its subsidiary Taro Pharmaceutical, is taking steps to ensure the safety and wellbeing of its employees and their families.Iran-Israel conflict: India Inc closely watches developments to ensure safety of employees in West Asia
Sun Pharma, which operates in Israel through its subsidiary Taro Pharmaceutical, is actively monitoring the situation in the country and is taking all necessary steps to ensure safety and wellbeing of employees and their families, a company spokesperson said in an email response to ET.Stock market update: Nifty Pharma index falls 0.65%
The Nifty Pharma index closed 0.65 per cent down at 18404.6.Stock market update: Nifty Pharma index falls 0.91%
The Nifty Pharma index closed 0.91 per cent down at 18617.65.As Middle-East tensions rise, these 14 Indian stocks have stakes in Israel
Middle-east tensions affect India markets with 14 stocks having Israel connections. Record-breaking rally faces uncertainty amid geopolitical concerns and rising oil/commodity prices. Analysts cautious about potential interest rate hikes.Hold Sun Pharma and Dr Reddy's; buy Natco on dips among pharma stocks: Mayuresh Joshi
Mayuresh Joshi shares insights on pharma and telecom sectors, focusing on key players like Sun Pharma, Dr Reddy's, Bharti Hexacom, and Exide. The discussion also includes Vodafone's FPO and the potential of Li-Ion battery makers.Stock market update: Nifty Pharma index falls 1.72%
The Nifty Pharma index closed 1.72 per cent down at 18788.65.Foram Parekh on what to bet on in pharma pack
Foram Parekh shares insights on CDMO companies' positive outlook post-Covid correction, potential impact of Biosecure Law, concerns about Laurus's earnings improvement, Sun Pharma's specialty sales focus, and recommendations for pharma sector growth with Lupin and Dr Reddy's.Sensex declines 650 points on fading US rate cut hopes; Nifty below 22,600
Indian indices dropped on U.S. inflation concerns. TCS to report Q4 results today. Sun Pharma, Asian Paints, Kotak Bank, NTPC, Maruti top laggards.Expat CEOs a rare commodity in India Inc
According to data sourced from Prime Database, there are 28 non-India expat CEOs among the 2,521 CEOs cumulatively appointed by 2,048 listed companies at end of FY24. The number of expat CEOs has hovered around the same levels over the past decade with several being individuals of Indian origin.Sensex rises 200 points, Nifty near 22,700 on gains in index heavyweights
Sensex and Nifty rise. Paytm CEO change and PB Fintech's new subsidiary affect stock prices. TCS to kickstart the quarterly results season. Global market factors influence trading sentiments.Ahead of Market: 10 things that will decide stock action on Monday
Indian shares rose as central bank rates remained stable. Nifty and Sensex gained 0.8%. HDFC Bank performed well. Analysts expect a sideways market. US markets closed higher, while European stocks fell due to Fed comments. Nagaraj Shetty says "the near-term trend of Nifty remains positive and the ongoing range movement is suggesting the possibility of sharp swing movement on either side. Hence a range expansion could be watched around 22600 and 22300 levels on either side.Fresh Peaks! Sensex surges 500 pts led by gains in HDFC Bank, Nifty scales Mt 22,600
Indian indices reach record highs ahead of RBI's decision. HDFC Bank reports strong growth. Power Grid, Axis Bank, Kotak Bank, Avenue Supermarts, KEC International show positive movement.Sensex snaps 3-day winning run, dips 111 points dragged by bank, IT stocks
Benchmark equity indices closed slightly lower on Tuesday due to mixed global cues. ICICI Bank, Kotak Bank, and IT stocks dragged the market. Sensex fell 111 points to settle at 73,904, while Nifty dropped 9 points to end at 22,453. The market capitalisation of all listed companies on the BSE surged by Rs 2.42 lakh crore to Rs 395.57 lakh crore. The market breadth was skewed in favour of the bulls.Nifty, Bank Nifty may see more gains, buy on dip’s the advice
Nifty has a short-term bottom at 21,710 and has its eyes set on a new all-time high with a potential to stretch higher till 23,000–23,100 from a one-month perspective.Hot Stocks: Brokerages view on Avenue Supermarts, Bajaj Finance, ICICI Bank and Sun Pharma
Brokerage firm HSBC maintained a buy rating on Sun Pharma, Citigroup recommended a buy rating on ICICI Bank, JPMorgan has an overweight rating on Bajaj Finance and CLSA recommended a buy rating on Avenue Supermarts.Pharma raw material makers in race to tank up on CXO talent
Some of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded Sekhmet Pharmaventures, and Carlyle-backed Viyash Lifesciences and Sequent Scientific (animal API manufacturer).Load More
BACK TO TOP